Intas
Custom Software Development · Manufacturing & Industrial Software
1open role
50+people
2020founded
13stories in the press
Overview
Intas is a software developer creating products for industrial enterprises. Its portfolio includes intas.data, intas.platform, GARD, Intas.EAM, Intas.Monitoring and Intas.SCADA for large industrial customers. The company is headquartered in Ufa, Bashkortostan, Russia.
Jobs
≈ $19k – $38k per year (Estimated) · Hybrid · Bachelor's Degree · Ufa
SQL
Microsoft Excel
Management
Agile
Scrum
BPMN
Apply
Growth
Hiring Momentum
41/100
Stable
Open positions
1
0 opened / 0 closed in 30 days
Median time-to-fill
13 days
faster than 70% of the market
ATS activity
Every ~1 days
11/04/2026
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Product
50% ▲
Analytics
50% ▼
Activity Timeline
Added Microsoft Excel to stack
Sep 2026
Added SQL to stack
Sep 2026
Added Figma to stack
Sep 2026
Added UML to stack
Sep 2026
Added Machine Learning to stack
Sep 2026
Added BPMN to stack
Sep 2026
Financials
Est. Annual Revenue
$4.8M
2025
People
Evgenii Loginov
Генеральный директор
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Tech stack
Technologies named in job postings at Intas over the last 12 months, by layer, with the share of postings for each.
Technologies in use
4
Postings analysed
2
Stack modernity
74/100
Languages
SQL
Cloud & platforms
Figma
Developer tools
Microsoft Excel
Practices & domains
Machine Learning
Sign in to see how your skills match this stack
Sign In
News
Intas Pharmaceuticals Ltd IPO 1970 Price, Date, Review and Key Insights
Intas Pharmaceuticals Ltd IPO 1970 - Get Intas Pharmaceuticals Ltd open and close date, listing date, price band, IPO lot size, allotment, subscription status, review, key insights, and much more only at Business Standard
Read more
Report
Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA
Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the world
Read more
Report
Intas eyes Biogen's biosimilars for $1 bn Company Business News
Ahmedabad-based Intas is being advised by Goldman Sachs Group Inc. and has submitted a non-binding bid and is seeking to put a binding one later this month
Read more
Report
Report
Prestige Biopharma and Intas Pharmaceuticals Announce Partnership to Commercialize Bevacizumab Biosimilar in the US, Europe, Canada, MENA, Brazil, Mexico, South Africa, CIS and ...
Read more
Report
Intas, Axantia ink agreement to commercialise Ranibizumab in Middle East
Ranibizumab: Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US.
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Ufa
Ufa
Russia
HQ
1 open roles 2 posted in 90 days 50-200 est. staff
hires for Product
ул. Дагестанская, д. 16/1, Уфа, Республика Башкортостан, 450050, RU